WallStreetZenWallStreetZen

NASDAQ: STRO
Sutro Biopharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for STRO

Based on 4 analysts offering 12 month price targets for Sutro Biopharma Inc.
Min Forecast
$12.00+264.74%
Avg Forecast
$17.50+431.91%
Max Forecast
$25.00+659.88%

Should I buy or sell STRO stock?

Based on 4 analysts offering ratings for Sutro Biopharma Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their STRO stock forecasts and price targets.

STRO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Truist Securities
Bottom 9%
9
Strong BuyReiterates$25.00+659.88%2023-09-06
JMP Securities
Bottom 3%
3
BuyReiterates$17.00+416.72%2023-08-14
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$16.00+386.32%2023-08-11
Wedbush
Top 11%
90
BuyMaintains$12.00+264.74%2023-08-11

1 of 1

Forecast return on equity

Is STRO forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is STRO forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

STRO revenue growth forecast

How is STRO forecast to perform vs Biotechnology companies and vs the US market?
Company
12.46%
Industry
35.17%
Market
8.14%
STRO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STRO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STRO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
STRO$3.29$17.50+431.91%Strong Buy
FATE$2.02$6.27+210.25%Buy
RIGL$1.14$8.50+645.61%Buy
MESO$1.23$6.83+455.53%Hold
IPHA$2.49$11.50+361.85%Buy
View Top Biotech Stocks

Sutro Biopharma Stock Forecast FAQ

Is Sutro Biopharma Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: STRO) stock is to Strong Buy STRO stock.

Out of 4 analysts, 1 (25%) are recommending STRO as a Strong Buy, 3 (75%) are recommending STRO as a Buy, 0 (0%) are recommending STRO as a Hold, 0 (0%) are recommending STRO as a Sell, and 0 (0%) are recommending STRO as a Strong Sell.

If you're new to stock investing, here's how to buy Sutro Biopharma stock.

What is STRO's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: STRO) forecast ROE is N/A, which is considered weak.

What is STRO's Price Target?

According to 4 Wall Street analysts that have issued a 1 year STRO price target, the average STRO price target is $17.50, with the highest STRO stock price forecast at $25.00 and the lowest STRO stock price forecast at $12.00.

On average, Wall Street analysts predict that Sutro Biopharma's share price could reach $17.50 by Sep 6, 2024. The average Sutro Biopharma stock price prediction forecasts a potential upside of 431.91% from the current STRO share price of $3.29.

What is STRO's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: STRO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.